Project W’s Post

Discover how #AI is revolutionizing the #LifeSciences industry! A staggering market growth is predicted for 2024-2032 due to the adoption of AI. The automation tech enhances efficiency and productivity, transforming drug discovery and clinical trials by reducing costs and accelerating execution. Pharma and biotech companies lead in demand for these tech advancements! 📈 What's next? Expect to see AI integration with existing systems, process automation, and data analysis influencing decision-making. Keen to know who the key players are? You might have more questions about this AI surge... Unlock the future of Life Sciences here 👉 https://lnkd.in/eaPdT3zc #DigitalTransformation #Pharmaceuticals #Biotechnology #Automation

I am excited to share that I recently attend the digital modules of One Day International workshop on Al and Machine Learning For Drug Discovery. our sessioned expert share valuable insights garnered from extensive experience in the field. #AIforDrugDiscovery #MachineLearning #DrugDiscovery #Pharma #Biotech #Research #Workshop #Innovation"

A data bottleneck was slowing high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Read the case study to learn more: https://lnkd.in/gjY_7-Pa

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/eWKkUPig

Lonza Unveils Cutting-Edge #AI-Enabled Route Scouting for Small Molecules 🧪 A really interesting read, after our blog post yesterday where we discussed the role of AI within the chemical world. Lonza, a global leader in the #pharmaceutical and #biotech industry, has recently launched an innovative AI-enabled route scouting service for small molecules. This groundbreaking offering combines Lonza's extensive process R&D expertise and supply chain databases with advanced AI-enabled computer-aided synthesis planning #technology from Elsevier's Reaxys platform. The complexity of modern small molecule drug candidates continues to increase, often requiring a higher number of synthetic steps to produce them. This can lead to longer lead times, more raw materials, and higher development costs. Lonza's AI-enabled route scouting service aims to streamline the identification of optimal synthetic routes, accelerating the development process and reducing associated costs. Key Features and Benefits 💠 Leverages cutting-edge AI technology for computer-aided synthesis planning 💠 Combines AI capabilities with Lonza's deep process R&D knowledge and supply chain data 💠 Facilitates efficient identification of optimal synthetic routes for complex small molecules 💠 Accelerates development timelines and reduces costs 💠 Enhances competitiveness in the rapidly evolving pharmaceutical landscape Lonza's commitment to innovation and leveraging advanced technologies positions the company as a frontrunner in the industry. This AI-enabled route scouting service is poised to revolutionise small molecule development, enabling faster time-to-market and more cost-effective processes. 📲 Read more: https://loom.ly/Lf-VwuA #ArtificialIntelligence #DrugDiscovery #pharmaceutical #biotech #DigitalTransformation #Innovation #SynthesisPlanning #GameChanger #FutureOfPharmam #AITechnology

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/g3-ny72K

For any of my network working in life Sciences, take the 50 seconds to watch the video below. And if you have a whole 7 minutes there is a lot more insights in the longer video https://lnkd.in/envCUxA7

Explore groundbreaking advancements in our application note, "Automation of the CRISPR-based cell line development workflow." Get a comprehensive look at how you can transform the landscape of pharmaceutical research with automated, high-throughput solutions. What You'll Discover: ✅ Efficiency and Scalability: Our integrated systems drastically reduce the time from transfection to clone productivity, enhancing both the speed and quality of cell line development. ✅ Precision in Monoclonality: With tools like our CloneSelect Imager FL, our workflows ensure high fidelity in clone selection and growth monitoring, crucial for therapeutic and vaccine development. ✅ Advanced Automation: Learn how our collaborative robots and sophisticated instrumentation streamline every step, from single-cell isolation to final validation assays, reducing human error and increasing reproducibility. By automating CRISPR workflows, we're not just accelerating research — we're paving the way for innovations that impact everything from drug discovery to sustainable food production. 👉 Elevate your research and contribute to solving global challenges. #CRISPR #SyntheticBiology #CellLineDevelopment #Automation #Biotech

💡 𝐅𝐚𝐜𝐢𝐧𝐠 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐢𝐧 𝐨𝐩𝐭𝐢𝐦𝐢𝐳𝐢𝐧𝐠 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬? AI has the power to revolutionize the way generics are developed, making them #faster, more #efficient, and cost #effective. Join our 𝐅𝐑𝐄𝐄 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 on S̳e̳p̳t̳e̳m̳b̳e̳r̳ ̳2̳7̳t̳h̳ to unlock #insights into how AI and in silico modeling are reshaping generic drug development. Don't miss out on key #industry trends and #strategies to stay ahead! ✨ 🔗 𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘕𝘰𝘸: https://lnkd.in/gxfXp7S6 📱 Scan the QR Code for easy registration! 𝑳𝒆𝒂𝒓𝒏 𝒉𝒐𝒘 𝒕𝒐 𝒕𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎 𝒚𝒐𝒖𝒓 𝒅𝒓𝒖𝒈 𝒅𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝒆𝒇𝒇𝒐𝒓𝒕𝒔 𝒘𝒊𝒕𝒉 𝒄𝒖𝒕𝒕𝒊𝒏𝒈-𝒆𝒅𝒈𝒆 𝑨𝑰. 𝑺𝒆𝒂𝒕𝒔 𝒂𝒓𝒆 𝒇𝒊𝒍𝒍𝒊𝒏𝒈 𝒖𝒑 𝒇𝒂𝒔𝒕—𝒓𝒆𝒔𝒆𝒓𝒗𝒆 𝒚𝒐𝒖𝒓𝒔 𝒕𝒐𝒅𝒂𝒚! #Webinar #pharma #drugdevelopment #ModelingAndSimulation #RegulatoryAffairs #Biosimilars #Generics #InSilico #biotechnology #LifeSciences #freewebinar InSilicoTrials

The pharmaceutical and biotechnology industry is undergoing a transformative shift due to the promise of artificial intelligence (AI). AI has the potential to revolutionize drug discovery and development, making processes more efficient, faster, and accurate. It could enable researchers and companies to discover novel medicines for patients with unmet needs. Find out more from David Bauer, Matt Bacal, Samantha Lefland and Ted Talas from Davis Polk & Wardwell LLP. Read the full hot topic from The Legal 500 Comparative Guides here - https://ow.ly/vtTr50QVtY9 #AI #pharmacuetical #biotechnology #law